Comparing Weight Loss Options

A physician-led guide to medical weight loss, endoscopic procedures, and bariatric surgery options.

Call 978-459-6737 for a consultation, or submit request below

Choosing the right weight-loss treatment

Obesity is a chronic, treatable disease. For many people, long-term weight management requires more than willpower or short-term dieting. Effective treatment may include lifestyle medicine, nutrition support, medication, endoscopic procedures, bariatric surgery, or a combination of these approaches.

At Integrated Gastroenterology Consultants, our Weight Management & Lifestyle Medicine Center helps patients understand the full range of treatment options. The goal is to match each patient with a safe, evidence-based plan that fits their medical history, weight-related conditions, prior treatment experience, and long-term goals.

IGIC provides physician-supervised weight management for patients in Lowell, Haverhill, Andover, the Merrimack Valley, Southern New Hampshire, and the greater Boston region.

Weight-loss treatment is a continuum

There is no single best weight-loss treatment for everyone. Some patients do well with intensive lifestyle treatment and nutrition counseling. Others benefit from FDA-approved medications. Some need an endoscopic procedure such as endoscopic sleeve gastroplasty or intragastric balloon therapy. Others are best served by bariatric surgery.

A comprehensive program allows patients to consider these options thoughtfully rather than viewing them as competing or unrelated treatments.

Treatment Options Comparison

Option	How it works	Best suited for	Key considerations
Lifestyle medicine & nutrition support	Structured support for nutrition, physical activity, sleep, stress, and behavior change.	Patients at any stage of weight management.	Foundational for long-term health; may be modest alone but supports all other treatments.
Weight-loss medications	Medications may reduce appetite, increase fullness, or affect metabolic signaling.	Patients who meet medical criteria and do not have contraindications.	Non-procedural and adjustable; requires medical supervision. Side effects, access, and coverage vary.
Endoscopic sleeve gastroplasty (ESG)	Endoscopic sutures reduce stomach volume without external incisions or stomach removal.	Selected adults seeking a procedural option without traditional bariatric surgery.	Incision-free and minimally invasive; requires anesthesia, staged diet, and follow-up.
Intragastric balloon	A temporary balloon is placed in the stomach to promote fullness.	Selected patients seeking a temporary, non-surgical endoscopic option.	Temporary and removable; nausea or intolerance can occur. Long-term success depends on follow-up.
TORe after gastric bypass	Endoscopic suturing reduces a dilated gastric bypass outlet in selected patients.	Patients with prior Roux-en-Y gastric bypass and weight regain related to outlet dilation.	Incision-free revision option; only applies to certain post-bypass patients.
Bariatric surgery	Surgical procedures alter stomach size and/or digestive anatomy.	Patients with more severe obesity or significant obesity-related conditions.	Often produces the greatest average weight loss; involves surgery, recovery, and lifelong monitoring.

Lifestyle medicine and nutrition support

Lifestyle treatment is the foundation of obesity care. This does not mean simply advising patients to “eat less and exercise more.” A structured lifestyle medicine approach addresses nutrition, physical activity, sleep, stress, behavior change, medical conditions, and the patient’s day-to-day environment.

At IGIC, lifestyle medicine may include nutrition counseling, health coaching, behavioral strategies, physical activity guidance, and programs designed to support sustainable change. Lifestyle treatment can be used alone or combined with medications, ESG, intragastric balloon therapy, TORe, or bariatric surgery.

Lifestyle treatment may be a good fit for patients who:

• Want to focus on metabolic health and long-term behavior change

• Prefer to start without medication or procedures

• Need support before or after a weight-loss procedure

• Have obesity-related conditions such as fatty liver disease, prediabetes, diabetes, high blood pressure, or high cholesterol

Weight-loss medications, including GLP-1 therapies

FDA-approved weight-loss medications can be effective tools for appropriate patients. Some medications, including GLP-1 receptor agonists and related therapies, work by reducing appetite, increasing satiety, slowing stomach emptying, or affecting metabolic signaling.

Medication selection should be individualized. Factors include BMI, medical history, diabetes status, cardiovascular risk, gastrointestinal symptoms, prior medication response, pregnancy considerations, side effects, cost, and insurance coverage.

Weight-loss medications may be a good fit for patients who:

• Meet medical criteria for pharmacologic weight management

• Prefer a non-procedural option

• Have weight-related medical conditions

• Need additional support beyond lifestyle treatment alone

• May benefit from medication before or after an endoscopic procedure

Important considerations include side effects, medication access, insurance coverage, dose adjustments, and the possibility of weight regain after stopping treatment. Medication therapy should be supervised by a clinician experienced in obesity medicine.

Endoscopic sleeve gastroplasty (ESG)

Endoscopic sleeve gastroplasty is an incision-free procedure performed through an upper endoscope. Sutures are placed inside the stomach to reduce its functional volume and create a narrower, sleeve-like shape. The goal is to help patients feel full with smaller meals and support long-term weight loss when paired with structured follow-up.

ESG may be a good fit for selected adults with obesity who:

• Want a procedural treatment but prefer to avoid traditional surgery

• Have not achieved durable weight loss with lifestyle treatment alone

• Are not ideal candidates for bariatric surgery or do not wish to pursue surgery

• Are willing to follow a staged diet and long-term weight management plan

• Understand that ESG is a tool, not a stand-alone cure

ESG may be especially relevant for patients who are looking for an option between medication therapy and bariatric surgery. It can also be combined with obesity medications in selected cases.

Intragastric balloon therapy

An intragastric balloon is a temporary, non-surgical device placed in the stomach to promote fullness and help patients reduce food intake. The balloon remains in place for a defined period and is then removed.

Balloon therapy may be a good fit for selected patients who:

• Prefer a temporary endoscopic option

• Want support initiating weight loss

• Are committed to nutrition and lifestyle follow-up

• May not be ready for a more durable procedure such as ESG or bariatric surgery

Because the balloon is temporary, long-term success depends on maintaining changes after balloon removal.

TORe for weight regain after gastric bypass

Transoral outlet reduction, or TORe, is an endoscopic procedure for selected patients who have regained weight after Roux-en-Y gastric bypass. In some patients, the connection between the stomach pouch and small intestine, called the gastrojejunal outlet, stretches over time. TORe uses endoscopic suturing to reduce the outlet size and help restore restriction.

TORe may be a good fit for patients who:

• Previously had Roux-en-Y gastric bypass

• Have experienced weight regain

• Have an enlarged outlet or anatomy that may respond to endoscopic revision

• Want an incision-free alternative to surgical revision

TORe is not a general weight-loss procedure for patients who have not had gastric bypass. An endoscopic evaluation is needed to determine whether it is appropriate.

Bariatric surgery

Bariatric surgery includes procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass. These operations can produce substantial and durable weight loss and may significantly improve obesity-related conditions such as type 2 diabetes, high blood pressure, sleep apnea, and fatty liver disease.

Bariatric surgery may be the best option for patients with more severe obesity, significant metabolic disease, or a need for the most powerful available weight-loss intervention. Surgery also requires careful preparation, recovery, and lifelong nutritional monitoring.

At IGIC, patients who may benefit from bariatric surgery can be evaluated within a broader medical and endoscopic weight management program and coordinated with surgical partners at Lowell General Hospital and Lawrence General Hospital when appropriate.

How to think about ESG vs medications

ESG and medications are different tools, and some patients may benefit from both.

Medications can be adjusted, stopped, or changed over time. They do not require a procedure, but they may require ongoing use to maintain benefit. Some patients experience side effects, difficulty with access, or inadequate response.

ESG is a one-time endoscopic procedure that changes stomach volume without removing stomach tissue. It requires anesthesia, recovery, a staged diet, and long-term follow-up. Some patients may still need medication after ESG, particularly if weight loss plateaus or if metabolic disease remains active.

The question is not simply “ESG or medication?” The more useful question is: “What combination of treatments gives this patient the safest and most durable path toward improved health?”

How to think about ESG vs bariatric surgery

ESG is less invasive than traditional bariatric surgery and does not involve removing part of the stomach. For some patients, that makes it an attractive option. However, bariatric surgery generally produces greater average weight loss and may be the more appropriate treatment for patients with more severe obesity or advanced metabolic disease.

Patients considering ESG should understand both the advantages and limitations of the procedure. Patients considering bariatric surgery should understand the benefits, risks, recovery, and lifelong nutritional monitoring required after surgery.

A physician-led consultation can help clarify which option is most appropriate.

Which option is right for me?

The best treatment depends on several factors:

• Current BMI

• Weight history and prior weight-loss attempts

• Diabetes, fatty liver disease, sleep apnea, hypertension, high cholesterol, or other weight-related conditions

• Prior gastrointestinal surgery

• Reflux, swallowing problems, ulcers, or other GI conditions

• Medication history and side effects

• Insurance coverage and cost considerations

• Preference regarding medication, procedures, and surgery

• Ability to participate in long-term follow-up

A careful evaluation helps avoid both undertreatment and overtreatment. Some patients need more intensive therapy earlier. Others may do well with a stepwise approach.

Why choose IGIC for weight management and bariatric endoscopy?

Integrated Gastroenterology Consultants offers a comprehensive, physician-led program for obesity and metabolic health. Our team includes clinicians with training in gastroenterology, obesity medicine, lifestyle medicine, nutrition, and advanced endoscopic procedures.

This matters because weight management is not just a cosmetic issue or a short-term goal. Obesity can affect the liver, digestive tract, cardiovascular system, endocrine system, joints, sleep, cancer risk, and overall health. A medically supervised program can help patients choose treatment based on health needs rather than trends or one-size-fits-all recommendations.

IGIC offers care for patients throughout Lowell, Haverhill, Andover, Newburyport, and across the Merrimack Valley, Southern New Hampshire, and the greater Boston region.

Frequently asked questions

Are GLP-1 medications better than ESG?

Not necessarily. GLP-1 medications and ESG work differently. Medications can be very effective for appropriate patients but require ongoing treatment and monitoring. ESG is an endoscopic procedure that reduces stomach volume. Some patients may benefit from one approach, and some may benefit from a combination.

Is ESG safer than bariatric surgery?

ESG is less invasive than bariatric surgery because it is performed through the mouth without external incisions and without removing stomach tissue. However, ESG still has risks and requires anesthesia, post-procedure care, and long-term follow-up. Safety depends on patient selection, procedural expertise, and clinical circumstances.

Is a balloon the same as ESG?

No. An intragastric balloon is temporary and must be removed. ESG uses endoscopic suturing to reduce the stomach’s functional volume. Both are endoscopic options, but they differ in durability, mechanism, and candidacy.

What is TORe?

TORe, or transoral outlet reduction, is an endoscopic revision procedure for selected patients who have regained weight after Roux-en-Y gastric bypass. It is not intended for patients who have not had gastric bypass.

Can I have ESG if I am taking a GLP-1 medication?

Possibly. Medication use before or after ESG is individualized. Some patients may stop, continue, or start medication depending on their response, side effects, medical conditions, and treatment goals.

Is weight-loss treatment covered by insurance?

Coverage varies widely by insurance plan and by treatment type. Medications, nutrition visits, endoscopic procedures, and bariatric surgery may have different coverage requirements. Patients should confirm benefits with their insurer and discuss options with IGIC’s billing team, who can discussion options such as payment plans.

Do I need a referral?

Referral requirements depend on insurance and the type of visit. Patients may contact IGIC directly to request a consultation, and the team can help determine the appropriate next step.

Request a weight management consultation

If you are considering medical weight loss, ESG, intragastric balloon therapy, TORe, or bariatric surgery, Integrated Gastroenterology Consultants can help you understand your options.

Our team provides physician-supervised care in Lowell, Haverhill, Andover, and across the Merrimack Valley, Southern New Hampshire, and the greater Boston region.

Call 978-459-6737 to request a Weight Management Consultation.

Sources:

• Jirapinyo P, de Moura DTH, Thompson CC, et al. American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on endoscopic bariatric and metabolic therapies for adults with obesity. Gastrointestinal Endoscopy. 2024;99(6):867-885.e64.

• Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity: a multicentre randomised controlled trial. The Lancet. 2022;400(10350):441-451.

• U.S. Food and Drug Administration. De Novo Classification Request for APOLLO ESG System, APOLLO ESG SX System, APOLLO REVISE System, and APOLLO REVISE SX System (DEN210045). FDA; 2022.

• U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management. FDA; 2023.

• U.S. Food and Drug Administration. ORBERA™ Intragastric Balloon System: Summary of Safety and Effectiveness Data / Premarket Approval P140008. FDA; 2015.

• American Society for Metabolic and Bariatric Surgery. Metabolic and Bariatric Surgery. ASMBS.

• Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders: indications for metabolic and bariatric surgery. Surgery for Obesity and Related Diseases. 2022;18(12):1345-1356.

• Mayo Clinic. Intragastric balloon: A re-emerging approach for obesity. Mayo Clinic.

Medically reviewed by Supriya Rao, MD
Last reviewed: 4/30/26
Integrated Gastroenterology Consultants Weight Management & Lifestyle Medicine Center